G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
53.30
+0.40 (0.76%)
Aug 29, 2025, 2:32 PM CST
0.76%
Market Cap3.14B
Revenue (ttm)294.26M
Net Income (ttm)134.60M
Shares Out59.00M
EPS (ttm)2.11
PE Ratio25.26
Forward PEn/a
Dividend0.70 (1.31%)
Ex-Dividend DateJul 29, 2025
Volume70,870
Average Volume40,613
Open52.60
Previous Close52.90
Day's Range52.40 - 53.40
52-Week Range41.67 - 57.13
Beta-0.90
RSI72.41
Earnings DateAug 7, 2025

About G&E Herbal Biotechnology

G&E Herbal Biotechnology Co., Ltd. engages in development and commercialization of novel botanical extraction technology and products. It offers Hepanamin capsules; botoniocal healthcare products; botanical anti-aging cosmetics, which includes facial cleansing essence, botonic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; and adult products, including lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 39
Stock Exchange Taipei Exchange
Ticker Symbol 4911
Full Company Profile

Financial Performance

In 2024, G&E Herbal Biotechnology's revenue was 249.03 million, an increase of 37.25% compared to the previous year's 181.44 million. Earnings were 102.06 million, an increase of 40.97%.

Financial Statements

News

There is no news available yet.